BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang H, Cui Z, Song Q. TUG1 as a Therapy Target in Pancreatic Cancer. Dig Dis Sci 2020;65:3756-7. [PMID: 33026604 DOI: 10.1007/s10620-020-06636-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu Q, Zhao H, Guo Y, Zhang K, Shang F, Liu T. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer. Journal of Healthcare Engineering 2022;2022:1-16. [DOI: 10.1155/2022/7904982] [Reference Citation Analysis]
2 Cheng S, Wang W. Analysis of the subcellular location of FAM230B and its interaction with premature miR-302b in osteosarcoma. J Bone Miner Metab 2022. [PMID: 35639175 DOI: 10.1007/s00774-022-01319-5] [Reference Citation Analysis]
3 Xiong G, Pan S, Jin J, Wang X, He R, Peng F, Li X, Wang M, Zheng J, Zhu F, Qin R. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer. Front Oncol 2021;11:765216. [PMID: 34760707 DOI: 10.3389/fonc.2021.765216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]